Available
Specifications
Manufacturer:
Active ingredient: Bucladesine Sodium
Shelf life:
Current price
$38
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
Indications for Use
- Treatment of HIV-1 infection in adults and adolescents aged 12 years and older, weighing at least 35 kg, as part of combination antiretroviral therapy.
Contraindications
- Hypersensitivity to emtricitabine, tenofovir alafenamide, or any excipients of the product.
- Severe renal impairment (creatinine clearance <30 mL/min).
- Concurrent use with other medications containing tenofovir or emtricitabine.
Adverse Effects
Common:
- Headache, nausea, diarrhea, fatigue.
Rare:
- Lactic acidosis, hepatomegaly, renal impairment, osteomalacia.
Very rare:
- Pancreatitis, rhabdomyolysis, allergic reactions.
Recommendations for Use
Administration:
- Take orally, preferably with food, once daily.
Special Instructions:
- Perform HIV testing and assess renal and hepatic function before initiating therapy.
- Regular monitoring of renal function and viral load is essential during treatment.
Drug Interactions:
- Avoid concurrent use with nephrotoxic drugs and other antiretroviral agents containing tenofovir or emtricitabine.
Before starting therapy, consult a healthcare provider and review the full prescribing information.
